Dmitry Balyasny’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.56M Buy
+11,700
New +$4.95M 0.01% 1409
2025
Q1
Sell
-320,000
Closed -$96M 2989
2024
Q4
$96M Buy
320,000
+317,600
+13,233% +$111M 0.14% 162
2024
Q3
$975K Buy
+2,400
New +$879K ﹤0.01% 1977
2020
Q4
Sell
-60,000
Closed -$7.48M 1485
2020
Q3
$7.48M Buy
+60,000
New +$7.43M 0.05% 476
2016
Q2
Sell
-250,000
Closed -$19.5M 1277
2016
Q1
$19.5M Buy
+250,000
New +$17.5M 0.12% 257
2013
Q3
Sell
-643,600
Closed -$23.2M 624
2013
Q2
$23.2M Buy
+643,600
New +$24.9M 0.39% 50

Other funds holding HCA

Dmitry Balyasny's HCA Position: Q2 2026 in Review

Dmitry Balyasny increased its HCA Healthcare (HCA) stake by 40% in Q2 2026, buying an estimated $429K and bringing the position to 3,523 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2029.

Dmitry Balyasny first reported a position in HCA in Q2 2013 and has held it in 42 quarters since. The position peaked at $63.9M in Q4 2023. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Dmitry Balyasny held 3,523 shares of HCA Healthcare worth $1.37M as of Q2 2026.
  • Dmitry Balyasny bought 1,015 HCA Healthcare shares in Q2 2026, an estimated $429K.
  • HCA Healthcare made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2029 holding.
  • Dmitry Balyasny first reported a position in HCA Healthcare in Q2 2013 and has held it in 42 quarters since.
  • Dmitry Balyasny's HCA Healthcare position peaked at $63.9M in Q4 2023.
  • 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.